We are international

October 26, 2001 Myeloma Minute

Tuesday, November 6, 2001
12 p.m. EST

The International Myeloma Foundation is pleased to present Perspectives in Multiple Myeloma: Directions Toward New Therapeutic Options, a LIVE, interactive CME teleconference. This teleconference will feature Dr. James Berenson (Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA) discussing Rationale and Future Directions and Dr. Mohamad Hussein (Cleveland Clinic, Cleveland, OH) discussing The Clinical Experience. This program is intended for general practicing oncologists and hematologists involved in the treatment of multiple myeloma.

We encourage our patient members to share this information with your physicians.

Myeloma News & Features:

FDA grants priority review for Zometa® in the treatment of a serious cancer complication.
(Novartis Press Release)

New data on Novartis drug Zometa for treatment of breast cancer and multiple myeloma-related bone complications published in major medical journal.
(Novartis Press Release)

Renal Failure Should Not Exclude Multiple Myeloma Patients from Receiving Autologous Stem Cell Transplants.
(Courtesy of Acurian.com)

Mayo Clinic Study Shows Thalidomide Significantly Affects Early-stage Multiple Myeloma.
(Courtesy of Acurian.com)

Items of Interest:

Many of the side effects from chemotherapy are well known, including fatigue, nausea and vomiting, and hair loss. But patients may not expect a decline in cognitive function, which includes thinking, memory, language skills, and concentration.
(Courtesy of CancerSource.com)

Clinical Trials:

Phase I Study of Apolizumab and Rituximab in Patients With Relapsed CD20 and ID10-Positive B-Cell Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia (Summary Last Modified 10/2001)

Phase I Study of STI571 in Patients with Advanced Malignancies (Summary Last Modified 10/2001)

Phase II Study of Allogeneic Bone Marrow Transplantation Using Closely Matched Related and Unrelated Donors In Patients With Malignant or Nonmalignant Hematologic 0isorders (Summary Last Modified 10/2001)

These clinical trials were added to the NCI's database during the month of October. For a comprehensive listing of ongoing clinical trials available for multiple myeloma patients, please visit our clinical trials page.

Coming Soon to a City Near You:

The IMF has a busy schedule planned for 2002. Dallas, TX, Bombay, India, Atlanta, GA, Vienna, Austria, Washington DC and Toronto, Ontario, Canada are just a few of the cities where we'll be hosting our famous educational Patient & Family Seminars. Be sure to watch our program calendar for important information about meeting dates and venues.

Now Available: New IMF Holiday Cards!

Spread some cheer this holiday season while supporting the IMF! Thanks to the artistic talents of our Jr. IMFers, we can now offer Christmas and Holiday greeting cards! Both Christmas and Holiday cards feature two different designs and are available in packages of 10 cards (five of each design) for a $20 donation. Pre-ordering is available now. Order online by clicking here, or call the IMF at (800) 452-CURE. Cards are in stock and ready for delivery. Quantities are limited.

IMFers on the Radio:

Don't miss IMFer Rosanne Kalick's radio appearance on the National Public Radio (NPR) show "The Satellite Sisters," on Saturday, November 3rd, 2001. The topic for the show is cancer etiquette and Rosanne can be heard speaking at length about multiple myeloma. In New York, the show airs at 4 p.m. on WNYC (93.9 FM). To find out when and where "The Satellite Sisters" can be heard in your area, please click here.

Tell A Friend...

The Myeloma Minute is a great way to stay abreast of the latest developments within the myeloma community. We hope you'll share this information with friends, family members and physicians and encourage them to sign up for their own copy by forwarding this message. New users can register by clicking here. You can also view back issues of Myeloma Minute online.

If you no longer wish to receive the Myeloma Minute, please visit the log-in page, enter your email address, password, first and last name and click the "unsubscribe" button at the bottom of the page.

 related articles